Targeting miR-103a-3p/IGFBP5 axis: a potential therapeutic strategy for gastric cancer progression

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Gastric cancer causes significant global mortality with limited therapeutic options.
• MicroRNAs are key regulators in cancer, influencing proliferation, migration, invasion, and apoptosis.
• The specific role of miR-103a-3p in gastric cancer pathogenesis is largely unknown.

Purpose of the Study:

• To investigate the expression and function of miR-103a-3p in gastric cancer.
• To identify the molecular targets and mechanisms underlying miR-103a-3p's role in gastric cancer progression.
• To evaluate the miR-103a-3p/IGFBP5 axis as a potential therapeutic target and prognostic marker.

Main Methods:

• Quantitative real-time PCR to assess miR-103a-3p expression in gastric cancer tissues and adjacent non-cancerous tissues.
• In vitro functional assays (proliferation, invasion, migration) to determine the effects of miR-103a-3p.
• Bioinformatic analysis and luciferase reporter assays to identify and validate miR-103a-3p targets.
• Rescue experiments with IGFBP5 overexpression to confirm its role in mediating miR-103a-3p effects.

Main Results:

• miR-103a-3p expression was significantly increased in gastric cancer tissues compared to non-cancerous tissues.
• Upregulation of miR-103a-3p enhanced gastric cancer cell proliferation, invasion, and migration.
• Insulin-like growth factor binding protein 5 (IGFBP5) was identified as a direct target of miR-103a-3p.
• Overexpression of IGFBP5 counteracted the pro-tumorigenic effects of miR-103a-3p.

Conclusions:

• The miR-103a-3p/IGFBP5 axis plays a critical role in promoting gastric cancer progression.
• miR-103a-3p functions as an oncogenic microRNA in gastric cancer by targeting IGFBP5.
• This axis represents a promising therapeutic target and prognostic biomarker for gastric cancer.